Ann: AnteoTech signs Non-Binding MOU with Wyon, page-128

so we have had 2 Mou's signed in the past few weeks

from your post

In the Webinar David said the Trinseo deal is the first of many to come.

And Conor recently made the following comment "The first of many Global Battery Value Chain Players to reach out to AnteoTech."


who could be the many more to come? on the 11th of July 2021 (8 months ago)

"AnteoX passes first stage evaluation by two international battery companies."

1/ "Enax who is a customer of Collaborator 8, has evaluated AnteoX in their high energy silicon anode reference design that is currently under development for a high-performance application"

"AnteoTech will continue working closely with the LIB developer to support its testing efforts and the integration of AnteoX into its processes and cell designs."

July 20 Colloborator 8 is "Very large northern Asian diversified electronics manufacturer with global
operations. "

oct 21 "Collaborator 8’s customer has agreed to evaluate AnteoX with the scope of the evaluation program currently being planned."

2/ "A large global battery manufacturer tested AnteoX in anodes containing >95% silicon as a method for testing the effect of AnteoX’s potential to improve the performance of various binders."

"Following the initial evaluation, the Manufacturer has expressed interest in conducting further testing on full cells and combining AnteoX with more commercial anode formulations. AnteoTech will work with the Manufacturer to progress to the next stage of testing."

you can understand from the above why the Trinseo Voltabond deal was for anode chemistries with silicon in the range 0-35%. it's left the higher silicon anode use open for a deal.

these 2 companies would have to be close to being mou 3&4. testing for a long time now. we know from the Dec San Diego presentation that one of our partners have completed a successful roll to roll coating trial completed with AnteoX, thats when the testing is at the final stages.....

we have, integration of AnteoX into its processes and cell designs, further testing on full cells and combining AnteoX with more commercial anode formulations from 8 months ago, roll to roll trial before Dec!!!

going to be an interesting period ahead with option conversion late this month. CMO starting on Wednesday and Ian presenting at the Merck Ivd conference in Rome 21/22nd of March.